Total equity distribution adjusted for changes in share capital of Zhuhai Keyu Biological Engineering Co., Ltd.
2023-06-19

Zhuhai Keyu Biological Engineering Co., Ltd. at the fifth meeting of the third session of the Board of Directors and the fourth meeting of the third session of the Supervisory Committee held on April 8, 2023, considered and approved the "Annual Report for the Year 2022". (hereinafter referred to as the "Company") was held on 8 April 2023, the Fifth Meeting of the Third Session of the Board of Directors and the Fourth Meeting of the Third Session of the Supervisory Committee considered and passed the  On April 10, 2023, the ''Announcement on the 2022 Annual Profit Distribution Proposal'' was disclosed on the designated information platform of the National Small and Medium Enterprises Stock Transfer System (www.neeq.com.cn) (Announcement (Announcement No.: 2023-023), the details of the profit distribution plan are as follows.


According to the Company's annual report for the year 2022 disclosed on April 10, 2023, as of December 31, 2022, the undistributed earnings attributable to the Parent Company in the consolidated statements of the listed companies were 45,131,082.50, and the undistributed earnings of the Parent Company were 47,674,651.75.


The total share capital of the Company is 32,800,000 shares, and the number of shares to be distributed on the share registration date when the distribution is to be implemented is based on the number of shares to be distributed on the share registration date. The total share capital of the Company is 32,800,000 shares, and it is proposed to distribute a cash dividend of RMB3.00 (including tax) per 10 shares to all shareholders based on the number of shares to be distributed on the share registration date at the time of the distribution. It is proposed to distribute a cash dividend of RMB3.00 per 10 shares to all shareholders based on the number of shares to be distributed on the share registration date when the equity distribution is implemented. It is expected that a total cash dividend of RMB9,840,000.00 will be distributed in this equity distribution. If the number of shares to be distributed on the share registration date is inconsistent with the current estimation, the Company will keep the distribution ratio unchanged and adjust the total amount of distribution accordingly. The total amount of distribution will be adjusted accordingly. The actual distribution results will be based on the results of China Securities Depository & Clearing Co. The actual distribution results will be based on the results of accounting by China Securities Depository & Clearing Co.


The above equity distribution proposal has been considered and approved by the Company at the 2022 Annual General Meeting of Shareholders to be held on May 12, 2023 The above equity distribution proposal has been considered and approved by the 2022 annual general meeting of the Company held on 12 May ,2023.


On March 13, 2023, the Company held the fourth meeting of the third session of the Board of Directors and the second meeting of the third session of the Supervisory Committee. The meeting considered and passed the "Draft Share Incentive Scheme of Zhuhai Techland Bioengineering Co. which was considered and approved at the Second Extraordinary General Meeting of 2023 held on May 4, 2023 by the Company. The Company intends to grant 1.34 million restricted shares to 38 core employees at a price of RMB4.00 per share.


As of May 24, 2023 (the payment deadline), 36 incentive recipients participated in the subscription, and the actual subscription the number of restricted shares was 1.22 million shares. The incentive recipients have deposited all the subscription funds of RMB4,880,000 into the Company's account. On May 26, 2023, Lixin Certified Public Accountants (Special Ordinary Partnership) conducted an audit of the subscription status of the share incentive recipients. subscription and issued the Capital Verification Report (No. ZM50014).


On June 16, 2023, the Company received the "Confirmation of Share Registration" (Business Order No. 128000000023) issued by China Securities Depository & Clearing Co. (Business Order No.: 128000000023), the registration date of which was June 15, 2023, from China Securities Depository & Clearing Co.


On June 19, 2023, the Company disclosed the "Announcement of Restricted Shares Grant Result under the Share Incentive Scheme" (Announcement No. (www.neeq.com.cn), the Company disclosed the Announcement on the Results of Restricted Share Award under the Share Incentive Scheme (Announcement No. 2023-048). No. 2023-048), the actual number of persons granted interests under the Share Incentive Scheme was 36, and the actual number of restricted shares granted was 1.22 million shares. The actual number of persons granted interests under the Share Incentive Scheme was 36, and the actual number of restricted shares granted was 1.22 million shares at a grant price of RMB4.00 per share. Upon completion of the registration of the grant under the Incentive Plan, the total number of shares of the Company will increase from 32,800,000 shares to 34,020,000 shares.


In view of the completion of the grant of the 2023 Equity Incentive Plan of the Company, the total share capital of the Company has changed from 32,800,000 shares 34,020,000 shares, according to the ''Announcement on the 2022 Annual Equity Distribution Proposal'' disclosed by the Company, the Company will Maintain the principle of unchanged distribution ratio to adjust this equity distribution plan.


According to the Company's annual report for 2022 disclosed on April 10, 2023, as of December 31, 2022, the Undistributed earnings attributable to the parent company in the consolidated statements of the listed company were 45,131,082.50, and the parent company's undistributed distributed profit was 47,674,651.75.


The total share capital of the Company is currently 34,020,000 shares, and it is proposed to distribute a cash dividend of RMB3.00 (including tax) per 10 shares to all shareholders on the basis of the number of shares to be allotted on the share registration date at the time of the implementation of the equity distribution and from the undistributed profits. A total cash dividend of RMB10,206,000.00 is expected to be distributed under the equity distribution, if the the number of shares to be distributed on the share registration date is inconsistent with the current estimation, the Company will keep the distribution ratio unchanged and adjust the total amount of distribution accordingly. The total amount of distribution will be adjusted accordingly. The actual distribution results shall be subject to the results of accounting by China Securities Depository & Clearing Corporation.


The Company apologizes for any inconvenience caused to investors as a result of the above adjustments.

Copyright © 2023 Zhuhai Keyu Biological Engineering Co., Ltd All rights reserved.     Yue ICP Bei No. 11016863号    Technical Support : e-net